“Acquisition or Disposal Notifications”), with a maximum transaction size equivalent to 6.90 percent calculated based on the Value of Consideration Criteria that compared the value of the paid consideration of
, 2004 (the “Acquisition or Disposal Notifications”), with a maximum transaction size equivalent to 6.90 percent calculated based on the Value of Consideration Criteria that compared the value of the paid
, 2004 (the “Acquisition or Disposal Notifications”), with a maximum transaction size equivalent to 6.90 percent calculated based on the Value of Consideration Criteria that compared the value of the paid
related to Offering for Sale of Units of Foreign Collective Investment Schemes and the Notifications of the Office of the Securities and Exchange Commission, guidelines, orders and circulars issued or
operating income ratio 24.3% 21.2% 27.3% 3.1% (3.0)% 22.7% 24.5% (1.8)% Expense to operating income ratio 56.2% 43.5% 45.5% 12.7% 10.7% 45.4% 43.5% 1.9% Return on average assets * 1.04% 1.14% 1.10% (0.10
Flow from Operating 255.4 188.0 Cash Flow from Investment (932.9) (2.9) Cash Flow from Financing (0.4) 0.0 Net Cash Flow 820.0 1,250 (Unit : THB mn) The Company has net cash flow as at 31st March, 2018
“SORKON” and its subsidiaries (“the company”) would like to clarify the operating results for Quarter 1/2018 as follows: Revenue and Net Sales The Company recorded its total revenue of Baht 696.5 million
Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for the year 2018 as follows:- Financial Position As at 31 December 2018, total consolidated assets
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
Public Company Limited Management Discussion and Analysis Operating Results for the period year ended 31 December 2018 Page 2 of 4 T.K.S. TECHNOLOGIES \ THB million Y18 Y17 %Chg As Reported (% to Sales